Literature DB >> 14630568

The possible role of tumor necrosis factor-alpha in diabetic polyneuropathy.

Jo Satoh1, Soroku Yagihashi, Takayoshi Toyota.   

Abstract

In this review, the authors provide evidences that imply the role of tumor necrosis factor-alpha (TNF-alpha) in the pathogenesis of diabetic complications, especially diabetic polyneuropathy. Under chronic hyperglycemia, endogenous TNF-alpha production is accelerated in microvascular and neural tissues, which may undergo an increased microvascular permeability, hypercoagulability, and nerve damage, thus initiating and promoting the development of characteristic lesions of diabetic microangiopathy and polyneuropathy. Enhanced TNF-alpha production may also promote atherosclerosis due to increased insulin resistance and the expression of adhesion molecules. Clinical application of specific agents that suppress production and/or activity of TNF-alpha may inhibit the development and exacerbation of chronic diabetic complications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630568      PMCID: PMC2478597          DOI: 10.1155/EDR.2003.65

Source DB:  PubMed          Journal:  Exp Diabesity Res        ISSN: 1543-8600


  34 in total

1.  Bone marrow-derived TNF-α causes diabetic neuropathy in mice.

Authors:  Hiroshi Urabe; Tomoya Terashima; Fan Lin; Hideto Kojima; Lawrence Chan
Journal:  Diabetologia       Date:  2014-11-16       Impact factor: 10.122

2.  Inactivation of TNF-α ameliorates diabetic neuropathy in mice.

Authors:  Isamu Yamakawa; Hideto Kojima; Tomoya Terashima; Miwako Katagi; Jiro Oi; Hiroshi Urabe; Mitsuru Sanada; Hiromichi Kawai; Lawrence Chan; Hitoshi Yasuda; Hiroshi Maegawa; Hiroshi Kimura
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-08-02       Impact factor: 4.310

3.  Elevated fibroblast growth factor-2 increases tumor necrosis factor-alpha induced endothelial cell death in high glucose.

Authors:  Alisa Morss Clyne; Han Zhu; Elazer R Edelman
Journal:  J Cell Physiol       Date:  2008-10       Impact factor: 6.384

4.  Effect of dipyrone and thalidomide alone and in combination on STZ-induced diabetic neuropathic pain.

Authors:  Neha Chauhan; Rajeev Taliyan; Pyare Lal Sharma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-01-17       Impact factor: 3.000

5.  Tumor necrosis factor-alpha mediates diabetes-enhanced apoptosis of matrix-producing cells and impairs diabetic healing.

Authors:  Rongkun Liu; Harbinder S Bal; Tesfahun Desta; Yugal Behl; Dana T Graves
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

6.  Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy.

Authors:  Mitra Tavakoli; Omar Asghar; Uazman Alam; Ioannis N Petropoulos; Hassan Fadavi; Rayaz A Malik
Journal:  Ther Adv Endocrinol Metab       Date:  2010-04       Impact factor: 3.565

Review 7.  Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain.

Authors:  Abhilasha Ahlawat; Ajay Rana; Nidhi Goyal; Saurabh Sharma
Journal:  Inflammopharmacology       Date:  2014-08-06       Impact factor: 4.473

Review 8.  Diabetic painful and insensate neuropathy: pathogenesis and potential treatments.

Authors:  Irina G Obrosova
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

9.  Effect of sesamol on diabetes-associated cognitive decline in rats.

Authors:  Anurag Kuhad; Kanwaljit Chopra
Journal:  Exp Brain Res       Date:  2007-10-23       Impact factor: 1.972

10.  Lack of TNFalpha expression protects anaplastic lymphoma kinase-positive T-cell lymphoma (ALK+ TCL) cells from apoptosis.

Authors:  Qian Zhang; Hong Y Wang; Gauri Bhutani; Xiaobin Liu; Michele Paessler; John W Tobias; Donald Baldwin; Kunchithapadam Swaminathan; Michael C Milone; Mariusz A Wasik
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.